News

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Sexual risk behavior is the strongest predictor of syphilis among HIV-infected MSM and the risk of infection doesn’t decrease with repeated episodes of the infection, a new study found.

Babies born with HIV benefit from beginning ART with days—not weeks—of birth.

The WHO Director-General Tedros Adhanom Ghebreyesus, PhD is not declaring the Wuhan Coronavirus outbreak a Public Health Emergency of International Concern at this time.

It appears that treatment with vitamin C, thiamine, and hydrocortisone does not significantly improve time alive and time free of vasopressor administration among patients with sepsis.

A study has revealed the ways Mycoplasma genitalium competes with host organism cells for essential metal nutrients.

Infection with C diff can increase hospital length of stay between 3 and 21 days, new research says.

The WHO International Health Regulations Emergency Committee convened on January 22rd to discuss the status of the coronavirus outbreak. The committee was split on their decision and will reconvene on January 23rd.

CDC estimates indicate that there have been 13 million influenza illnesses, 120,000 hospitalizations, and 6600 flu-related deaths so far this season.

A report suggests governments can significantly reduce the economic toll of epidemics with a (relatively) small investment.

Public Health England reported the promising news that new HIV transmission in the UK continued to decline in 2018.

Traditional influenza surveillance typically has a 1- to 3-week reporting lag and is usually preliminary and revised as more information becomes available. Therefore, more accurate surveillance tools are needed.

The case has been confirmed in an individual in Washington State.

A significant relationship exists between environmental exposures and colonization.

Treating patients with multidrug-resistant Pseudomonas aeruginosa infections could be moved to the outpatient setting with continuous infusion dosing of ceftolozane/tazobactam, a new study suggests.

A new study examining conjugate vaccine trial data has concluded that typhoid incidence estimates should be adjusted for the proportion of cases which go undetected due to lack of blood cultures.

According to CDC data, 34 cases of EEE were recorded in humans in 2019. In total, 94% of patients were diagnosed with encephalitis and 6% were diagnosed with meningitis.

Investigators of a new analysis detail how Ebola case definitions became increasingly complex and discordant during the 6-month period in the countries surrounding the DRC.

Where do infectious diseases fall on the WHO’s list of challenges to address during the 2020s?

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of January 12, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The CDC has announced that travelers from Wuhan will undergo entry screening at airports in New York, San Francisco, and Los Angeles.

Sepsis may be associated with 1 in 5 deaths globally, twice as many as some previous estimates established.

A new study has found that in Tennessee, less than 2% of providers account for 25% of pediatric antibiotic prescriptions, with the highest number of prescriptions coming from providers who graduated from medical school prior to 2000.

Using a trial of antibiotics may be useful for predicting tuberculosis in ambulatory patients with HIV, particularly in settings with limited access to resources, a new study suggests.

Although antiretroviral therapy restores a patient with HIV’s immune system, lingering damage from HIV can render past vaccinations obsolete, a new study finds.

A new study conducted by CDC investigators found that commercially insured patients persisted on PrEP for median time of 13.7 months, compared to 6.8 months among Medicaid patients.

A new study demonstrates that some HIV "hotspots" transfer very few infections to nearby communities and instead receive more infections from outside.